EssilorLuxottica unveils smart glasses as stock hits 52-week low ahead of earnings
EssilorLuxottica is preparing to release its first-quarter revenue results on 22 April 2026. The announcement comes as the company's share price hits a 52-week low, falling 21.56% since January. Investors are also considering a proposed dividend of €4.00 per share.
At the same time, the eyewear giant is showcasing new technology at the SWITCH: Vision Innovation Summit in Orlando. Products on display include smart glasses and medical advancements like the Stellest lens, designed to slow myopia in children.
The company's stock closed at €209.50, its lowest point in a year. This marks a sharp drop from its November 2025 peak of over €323. Despite the decline, EssilorLuxottica exceeded executive performance targets by 179.6% in 2025, leading to multimillion-euro bonuses for CEO Francesco Milleri and deputy Paul du Saillant.
In Orlando, the firm is unveiling updates to its Ray-Ban Meta collection and launching Oakley Meta, developed with major tech partners. These products highlight its push into smart eyewear and digital integration. Beyond consumer tech, EssilorLuxottica is expanding into medical solutions. The Stellest lens, aimed at children with myopia, represents a key step into healthcare innovation. The company's focus on both fashion and function reflects its broader strategy to diversify beyond traditional eyewear. With earnings due next week, analysts will watch whether the new product lines can offset recent stock performance. The proposed dividend suggests confidence in long-term stability, even as shares struggle.
EssilorLuxottica's upcoming earnings report will provide clarity on its financial health amid a challenging market. The dividend proposal and new product launches signal efforts to balance investor returns with growth in emerging sectors. How these moves affect share prices and revenue will become clearer after the 22 April announcement.
